Page 309 - SAHCS HIVMed Journal Vol 20 No 1 2019
P. 309

Page 5 of 7  Original Research


              analysis. This result disappeared after adjustment for sex and   the participants reported cough in our study. Bringing up
              age. Additional adjustment for CD4-cell count and viral load   phlegm was reported by 30% of HIV-negative and 42% of
              did not change the findings.                          PLHIV in studies conducted in HIC,  18,21,24  whereas this was
                                                                    reported by only 2% of the participants in our study. Both
              The occurrence of any respiratory complaint was associated   coughing and bringing up phlegm were reported to happen
              with age, female sex, BMI and a history of bronchial     more in PLHIV than in HIV-negative participants. 18,21,24
              hyper-reactivity (Table 4). When limiting  the analysis     Wheezing and whistling have only been evaluated in two
              to breathlessness, age, female sex, BMI, bronchial     studies from HIC. No difference was found between PLHIV
              hyper-reactivity and a history of pulmonary infection were   and HIV-negative participants. 24,25
              the associating factors (Table 5).
                                                                    In contrast, breathlessness was a frequently expressed
              Discussion                                            complaint with 22% of the participants in our study,
                                                                    indicating that they experienced breathlessness. This is in
              The  frequency  of respiratory  complaints  in our study  was   line  with  the  literature,  mostly  from  HIC,  reporting  that
              surprisingly low when compared to what has been reported   between 1.4% and 42% of the population experience
              in the literature in studies from both HIC and LMIC. For   breathlessness. People living with HIV were found to
              coughing, a frequency of 17%   – 40%   has been reported in   experience breathlessness more often than HIV-negative
                                            18
                                      17
              HIC and 7% – 48%  19,20,21,22,23  in LMIC. In contrast, only 3.3% of   individuals, 18,25,26  a finding that we could not confirm in
                                                                    our study.
              TABLE 3: Any respiratory symptom for all participants.
              Model     HIV-              HIV-positive              The following reasons should be considered to understand
                       negative
                               ART-naïve  First-line ART  Second-line ART  the low number of respiratory complaints, except for
                              OR  95% CI  OR   95% CI  OR  95% CI   breathlessness, noted among the participants in our study
              Model 1: HIV  REF  1.11  0.60–2.07  0.84  0.43–1.64  2.52 1.54–4.12*  compared to previous studies. Firstly, our study population
              Model 2: HIV +   REF  1.01  0.53–1.93  0.70  0.35–1.40  1.55  0.91–2.64
              age + sex                                             differed from study populations in HIC. People living
              Model 3: HIV +   REF  1.19  0.59–2.40  0.80  0.39–1.68  1.32  0.70–2.48  with HIV from HIC represent a particular group with
              age + sex +                                           specific health risk behaviour, such as men having sex
              other factors†
              ART, antiretroviral therapy; OR, odds ratio; CI, confidence interval; REF, reference group.  with men (MSM) or intravenous drug users with a higher
                                                                                                                   27
              †,  Other factors: body mass index, ever smoking, passive smoking, respiratory infections in   percentage of smokers than the HIV-negative population.
               the past (pneumonia and/or tuberculosis), bronchial hyper-reactivity.   In our study cohort, PLHIV smoked significantly less than
              *, p < 0.05, 1.
              TABLE 4: Factors associated with any respiratory symptom.
              Variable                   Univariable OR  95% CI         p         Multivariable OR  95% CI      p
              HIV-positive                  1.65        1.05–2.60      0.03        1.13 (0.65–1.96)  0.65–1.96  0.66
              Age (per 5 years increase)    1.26        1.13–1.39      < 0.01      1.20 (1.06–1.35)  1.06–1.35  < 0.01*
              Female sex                    3.49        2.20–5.54      < 0.01      2.40 (1.38–4.17)  1.38–4.17  < 0.01*
              BMI                           1.11        1.07–1.14      < 0.01      1.07 (1.04–1.11)  1.04–1.11  < 0.01*
              Ever smoking                  0.50        0.31–0.80      < 0.01      1.05 (0.60–1.83)  0.60–1.83  0.88
              Passive smoking               0.95        0.59–1.52      0.82            -              -         -
              Respiratory infection in the past†  1.76   1.16–2.66     < 0.01      1.36 (0.84–2.22)  0.84–2.22  0.22
              Bronchial hyper-reactivity    3.70        1.92–7.13      < 0.01      2.25 (1.11–4.57)  1.11–4.57  0.03*
              Environmental exposure‡       1.52        0.66–3.50      0.32            -                        -
              BMI, body mass index; CI, confidence interval; OR, odds ratio.
              †, Defined as either a history of pneumonia or TB.
              ‡, defined as work in the mining industry or in a dusty job for > 1 year or any exposure to gas, chemical fumes or pesticides in work ≥ 1 year.
              *, statistically significant at p < 0.05.
              TABLE 5: Factors associated with breathlessness.
              Variable                    Univariable OR     95% CI       p        Multivariable OR   95% CI     p
              HIV-positive                1.68 (1.03–2.76)  1.03–2.76)   0.04      1.01 (0.54–1.89)  0.54–1.89  0.98
              Age (per 5 years increase)  1.34 (1.20–1.50)  1.20–1.50    < 0.01    1.34 (1.17–1.55)  1.17–1.55  < 0.01*
              Female sex                  5.17 (2.95–9.04)  2.95–9.04    < 0.01    3.59 (1.82–7.07)  1.82–7.07  < 0.01*
              BMI                         1.12 (1.09–1.16)  1.09–1.16    < 0.01    1.08 (1.04–1.12)  1.04–1.12  < 0.01*
              Ever smoking                0.31 (0.18–0.56)  0.18–0.56    < 0.01    0.67 (0.34–1.32)  0.34–1.32  0.25
              Passive smoking             0.84 (0.50–1.40)  0.50–1.40    0.50          -                -        -
              Respiratory infection in the past†   2.13 (1.38–3.29)  1.38–3.29  < 0.01  1.76 (1.04–3.00)  1.04–3.00  0.04*
              Bronchial hyper-reactivity  4.07 (2.10–7.89)  2.10–7.89    < 0.01    2.15 (1.02–4.51)  1.02–4.51  0.04*
              Environmental exposure‡     0.84 (0.31–2.27)  0.31–2.27    0.73          -                -        -
              BMI, body mass index; CI, confidence interval; OR, odds ratio.
              †, Defined as either a history of pneumonia or TB.
              ‡, defined as work in the mining industry or in a dusty job for > 1 year or any exposure to gas, chemical fumes or pesticides in work ≥ 1 year.
              *, statistically significant at p < 0.05.

                                           http://www.sajhivmed.org.za 302  Open Access
   304   305   306   307   308   309   310   311   312   313   314